Kasey L Gildersleeve1, Mohammad I Hirzallah1, Yoshua Esquenazi2, Charles J Moomaw3, Padmini Sekar3, Chunyan Cai4, Nitin Tandon2, Daniel Woo3, Nicole R Gonzales5. 1. Department of Neurology, McGovern Medical School, Houston, Texas. 2. Vivian L. Smith Department of Neurosurgery, The University of Texas Health Science Center at Houston, Houston, Texas. 3. Department of Neurology and Rehabilitation Medicine, University of Cincinnati College of Medicine, Cincinnati, Ohio. 4. Department of Internal Medicine, McGovern Medical School, Houston, Texas. 5. Department of Neurology, McGovern Medical School, Houston, Texas. Electronic address: Nicole.R.Gonzales@uth.tmc.edu.
Abstract
BACKGROUND AND PURPOSE: Spontaneous supratentorial intracerebral hemorrhage (ICH) contributes disproportionately to stroke mortality, and randomized trials of surgical treatments for ICH have not shown benefit. Decompressive hemicraniectomy (DHC) improves functional outcome in patients with malignant middle cerebral artery ischemic stroke, but data in ICH patients is limited. We hypothesized that DHC would reduce in-hospital mortality and poor functional status (defined as modified Rankin scale ≥5) among survivors at 3 months, without increased complications. METHODS: We performed a retrospective, case-control, propensity score matched study to determine whether hemicraniectomy affected outcome in patients with spontaneous supratentorial ICH. The propensity score consisted of variables associated with outcome or predictors of hemicraniectomy. Forty-three surgical patients were matched to 43 medically managed patients on ICH location, sex, and nearest neighbor matching. Three-month functional outcomes, in-hospital mortality, and in-hospital complications were measured. RESULTS: In the medical management group, 72.1% of patients had poor outcome at 3 months compared with 37.2% who underwent hemicraniectomy (odds ratio 4.8, confidence interval 1.6-14). In-hospital mortality was 51.2% for medically managed patients and 16.3% for hemicraniectomy patients (odds ratio 8.5, confidence interval 2.0-36.8). There were no statistically significant differences in the occurrence of in-hospital complications. CONCLUSIONS: In our retrospective study of selected patients with spontaneous supratentorial ICH, DHC resulted in lower rate of in-hospital mortality and better 3-month functional status compared with medically managed patients. A randomized trial is necessary to evaluate DHC as a treatment for certain patients with spontaneous supratentorial ICH.
BACKGROUND AND PURPOSE: Spontaneous supratentorial intracerebral hemorrhage (ICH) contributes disproportionately to strokemortality, and randomized trials of surgical treatments for ICH have not shown benefit. Decompressive hemicraniectomy (DHC) improves functional outcome in patients with malignant middle cerebral artery ischemic stroke, but data in ICHpatients is limited. We hypothesized that DHC would reduce in-hospital mortality and poor functional status (defined as modified Rankin scale ≥5) among survivors at 3 months, without increased complications. METHODS: We performed a retrospective, case-control, propensity score matched study to determine whether hemicraniectomy affected outcome in patients with spontaneous supratentorial ICH. The propensity score consisted of variables associated with outcome or predictors of hemicraniectomy. Forty-three surgical patients were matched to 43 medically managed patients on ICH location, sex, and nearest neighbor matching. Three-month functional outcomes, in-hospital mortality, and in-hospital complications were measured. RESULTS: In the medical management group, 72.1% of patients had poor outcome at 3 months compared with 37.2% who underwent hemicraniectomy (odds ratio 4.8, confidence interval 1.6-14). In-hospital mortality was 51.2% for medically managed patients and 16.3% for hemicraniectomy patients (odds ratio 8.5, confidence interval 2.0-36.8). There were no statistically significant differences in the occurrence of in-hospital complications. CONCLUSIONS: In our retrospective study of selected patients with spontaneous supratentorial ICH, DHC resulted in lower rate of in-hospital mortality and better 3-month functional status compared with medically managed patients. A randomized trial is necessary to evaluate DHC as a treatment for certain patients with spontaneous supratentorial ICH.
Authors: Daniel Woo; Jonathan Rosand; Chelsea Kidwell; Jacob L McCauley; Jennifer Osborne; Mark W Brown; Sandra E West; Eric W Rademacher; Salina Waddy; Jamie N Roberts; Sebastian Koch; Nicole R Gonzales; Gene Sung; Steven J Kittner; Lee Birnbaum; Michael Frankel; Fernando Daniel Testai; Christiana E Hall; Mitchell S V Elkind; Matthew Flaherty; Bruce Coull; Ji Y Chong; Tanya Warwick; Marc Malkoff; Michael L James; Latisha K Ali; Bradford B Worrall; Floyd Jones; Tiffany Watson; Anne Leonard; Rebecca Martinez; Ralph I Sacco; Carl D Langefeld Journal: Stroke Date: 2013-09-10 Impact factor: 7.914
Authors: Lewis B Morgenstern; J Claude Hemphill; Craig Anderson; Kyra Becker; Joseph P Broderick; E Sander Connolly; Steven M Greenberg; James N Huang; R Loch MacDonald; Steven R Messé; Pamela H Mitchell; Magdy Selim; Rafael J Tamargo Journal: Stroke Date: 2010-07-22 Impact factor: 7.914
Authors: Christian Fung; Michael Murek; Werner J Z'Graggen; Anna K Krähenbühl; Oliver P Gautschi; Philippe Schucht; Jan Gralla; Karl Schaller; Marcel Arnold; Urs Fischer; Heinrich P Mattle; Andreas Raabe; Jürgen Beck Journal: Stroke Date: 2012-10-30 Impact factor: 7.914
Authors: Simon G Heuts; Samuel S Bruce; Brad E Zacharia; Zachary L Hickman; Christopher P Kellner; Eric S Sussman; Michael M McDowell; Rachel A Bruce; E Sander Connolly Journal: Neurosurg Focus Date: 2013-05 Impact factor: 4.047
Authors: A David Mendelow; Barbara A Gregson; Elise N Rowan; Gordon D Murray; Anil Gholkar; Patrick M Mitchell Journal: Lancet Date: 2013-05-29 Impact factor: 79.321
Authors: Daniel F Hanley; Richard E Thompson; John Muschelli; Michael Rosenblum; Nichol McBee; Karen Lane; Amanda J Bistran-Hall; Steven W Mayo; Penelope Keyl; Dheeraj Gandhi; Tim C Morgan; Natalie Ullman; W Andrew Mould; J Ricardo Carhuapoma; Carlos Kase; Wendy Ziai; Carol B Thompson; Gayane Yenokyan; Emily Huang; William C Broaddus; R Scott Graham; E Francois Aldrich; Robert Dodd; Cristanne Wijman; Jean-Louis Caron; Judy Huang; Paul Camarata; A David Mendelow; Barbara Gregson; Scott Janis; Paul Vespa; Neil Martin; Issam Awad; Mario Zuccarello Journal: Lancet Neurol Date: 2016-10-11 Impact factor: 44.182
Authors: Julia Masomi-Bornwasser; Elena Kurz; Christina Frenz; Jan Schmitt; Dominik M A Wesp; Jochem König; Johannes Lotz; Florian Ringel; Thomas Kerz; Harald Krenzlin; Naureen Keric Journal: Biomolecules Date: 2021-11-01